The top 20 biopharmas demonstrated a strong start to 2025, despite ongoing uncertainty surrounding Trump’s tariffs.

The Nasdaq Composite has been a goldmine for investors, powered by technology, artificial intelligence, and visionary companies that drive the future. In 2024, ...

Global Data has revealed that the Top 20 Global Biopharmaceutical Companies have witnessed a 6 % growth in market ...

Co-founder Finny Kuruvilla manages the firm’s largest two funds — Eventide Gilead and Eventide Healthcare and Life Sciences — and remains the firm’s largest owner, though more than 20 of ...

Less than three years after being spun out of Oxford University, privately-held biotech MiroBio is heading for a takeover by Gilead Sciences in a $405 million deal. MiroBio was formed in 2019 to ...

Gilead Sciences is just a few weeks away from an FDA decision on seladelpar for rare liver disease primary biliary cholangitis (PBC) and will be buoyed by new data pointing to its long-term ...

BlackRock Health Sciences Opps Port earns an Average Process Pillar rating. The most notable contributor to the rating is the parent firm's five-year risk-adjusted success ratio of 58%.

RPG Life Sciences Ltd., incorporated in the year 2007, is a Small Cap company (having a market cap of Rs 3,641.56 Crore) operating in Pharmaceuticals sector. RPG Life Sciences Ltd. key ...